Lung Cancer Clinical Trial
Official title:
Six-Minute Walk Test in the Evaluation of Patients at High Risk for Complications From Lung Resection
The goal of this clinical research study is to compare the 6-minute walk test with the exercise stress test, in patients who may have lung surgery. Researchers want to find out if the 6-minute walk test is as good as the exercise stress test at predicting possible complications that may occur after lung surgery.
Description of the Study Tests:
The exercise stress test is commonly used for predicting possible complications that may
occur after lung surgery. The 6-minute walk test is a simpler test that does not require as
much equipment.
6-Minute Walk Test: If you agree to take part in this research study, you will be asked to
perform two 6-minute walk tests along with your routine exercise stress test. Both 6-minute
walk tests will be done within 15 Days of the already scheduled exercise stress test if your
clinical condition does not change during that time period. The 6-minute walk tests should be
done at least 2 hours before or 1 hour after the exercise stress test. The second 6-minute
walk test may be done 20 minutes after the first one. If you had a 6-minute walk test done
within 15 Days before enrolling in the study, it can be used for the study.
To perform the 6-minute walk tests, you will walk as far as possible around cones on a flat
indoor course that is about 40 yards long. You will walk at your own pace and can take breaks
at any time if necessary. After the 6 minutes, the study staff will tell you the total
distance you have walked.
Researchers will compare the distances you walked for the two 6-minute walk tests with the
results of the exercise stress test. The walk test results will not affect your treatment
plan.
Other Study Procedures:
Before and after the walk tests, the following procedures will be performed. Your blood
pressure will be measured. You will be asked about any shortness of breath and/or fatigue you
may have.
Before, during, and for about 1 minute after the walk tests, your heart rate will be
measured. A device that looks like a clothespin will be placed on your finger to wear during
this time, and it will measure the amount of oxygen in your blood.
Length of Study:
You will be considered off-study after the second walk test.
If you do have lung surgery, researchers will monitor your health status by checking your
medical records until you are discharged from the hospital or for 30 days after the lung
surgery, whichever comes first.
This is an investigational study. Using the 6-minute walk test for this study's purpose is
considered experimental. Up to 101 patients will take part in this study. All will be
enrolled at M. D. Anderson.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
| Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
| Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
| Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
| Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
| Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
| Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
| Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
| Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
| Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
| Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
| Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|